1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

Wedgewood Partners Comments on Perrigo

August 31, 2012 | About:

Perrigo (NYSE:PRGO) positively contributed to performance during the quarter after the Company reported a 32% increase in adjusted income from continuing operations and subsequently received FDA approval for five new prescription and over-the-counter (OTC) pharmaceuticals. Over $15 billion in OTC pharmaceuticals will lose patent protection over the next several years and Perrigo, as the largest manufacturer of private-label, OTC pharmaceuticals, will have ample opportunity to provide its value-added services to retailers around the globe. During the quarter, shares of the company traded to valuation levels that were not as attractive as they have been in the past, so we trimmed positions in Perrigo.

From Tony Guerrerio's second quarter letter.


Rating: 2.4/5 (8 votes)

Comments

Please leave your comment:


GuruFocus has detected 3 Warning Signs with Perrigo Co PLC $PRGO.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

User Generated Screeners


foxjames1GROWTH
Hendrixlp70safe
Hendrixlp70Peter Lynch
donkyfaceNew 2017
TFC$1P/FCF EV/EBIT
Bear03Low B/S w Fscore>=5, CurR 1.2
Bear03Fundamental w/Value
Bear03Book Growth/Moderate PE/Good S
CortlandPeter Lynch l
sarahgolliheroptions
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK